About HA 2019

The next International Society for Hyaluronan Sciences conference will be held in Cardiff (Wales, UK) on June 9-13, 2019

The 12th International Conference of the International Society for Hyaluronan Sciences will bring together clinicians and scientists from academia and industry from all over the world to meet and discuss recent advances in the basic science, clinical application and biotechnology of Hyaluronan.

There will be 10 sessions covering the role of HA in Cardiovascular and Pulmonary disease, Stem cells, Growth and Differentiation, the Physics, Chemistry and Structure of HA, the Metabolism and Assembly of HA, HA in Renal, Diabetic and Joint disease, HA signaling pathways, Novel Mechanisms of HA involvement, HA in Immunity and Inflammation, Cancer Biology and in Development and Ageing.

The meeting will honour Professor Thomas Wight and his work on the role of Hyaluronan and Proteoglycans in Vascular Disease.

The Meeting Banquet will be held in the medieval splendor of Caldicot Castle.

About ISHAS
Mission
Founding Members
Previous Conferences

About ISHAS

The International Society for Hyaluronan Sciences is organized and shall at all times be operated exclusively for charitable and educational purposes in order to conduct the following activities, but only to the extent consistent with the other provisions of the Certificate of Incorporation and with Section 501(c)(3) of the Internal Revenue Code of 1986:

ISHAS Mission

MISSION

To advance knowledge on the structure, function and therapeutic application of hyaluronan and its role in the structure and function of the extracellular matrix and cells;

to support scientific research on the hyaluronan molecule encompassing all 3 branches of medical sciences: basic, clinical and applied;

The founding members of the Society came together during the International Hyaluronan meeting (Cleveland, Ohio, USA) in October 2003, during a round table discussion.

The Founders formally agreed to take part in the formation of the society, which was then officially incorporated by Dr. Endre Balazs and Dr. Vincent Hascall on October 4, 2004.